Search research articles
Contact Us
Filters
Showing results (171-180 of 204) with videos related to
Page
of 21
Sort By:
Genome Biology
|
December 25, 2015
Local compartment changes and regulatory landscape alterations in histone H1-depleted cells
Geert Geeven, Yun Zhu, Byung Ju Kim, et al.
Elife
|
December 13, 2022
Spinal premotor interneurons controlling antagonistic muscles are spatially intermingled
Remi Ronzano, Sophie Skarlatou, Bianca K Barriga, et al.
Nature Communications
|
March 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial
Rebecca L Porter, Yinglu Zhou, Nebiyat Eskndir, et al.
Nature Communications
|
August 20, 2025
Non-genetic neuromodulation with graphene optoelectronic actuators for disease models, stem cell maturation, and biohybrid robotics
Elena Molokanova, Teng Zhou, Pragna Vasupal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2024
Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer
A Di Federico, S L Alden, J W Smithy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 10, 2005
A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility
Jennifer L Shepard, James F Amatruda, Howard M Stern, et al.
Cancer Immunology Research
|
April 11, 2025
First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Metastatic Melanoma Patients
F Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie, et al.
JAMA Oncology
|
October 24, 2024
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial
Kartik Sehgal, Theodora Pappa, Kee-Young Shin, et al.
Nature Communications
|
December 31, 2024
Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma
Julia Paczkowska, Ming Tang, Kyle T Wright, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Positive Selection Screen for Natural Product β-Catenin Inactivators
Matthew W Boudreau, Vitor F Freire, Sophie C Corbett, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 204) with videos related to
Sort By:
Page
of 21
Genome Biology
|
December 25, 2015
Local compartment changes and regulatory landscape alterations in histone H1-depleted cells
Geert Geeven, Yun Zhu, Byung Ju Kim, et al.
Elife
|
December 13, 2022
Spinal premotor interneurons controlling antagonistic muscles are spatially intermingled
Remi Ronzano, Sophie Skarlatou, Bianca K Barriga, et al.
Nature Communications
|
March 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial
Rebecca L Porter, Yinglu Zhou, Nebiyat Eskndir, et al.
Nature Communications
|
August 20, 2025
Non-genetic neuromodulation with graphene optoelectronic actuators for disease models, stem cell maturation, and biohybrid robotics
Elena Molokanova, Teng Zhou, Pragna Vasupal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2024
Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer
A Di Federico, S L Alden, J W Smithy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 10, 2005
A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility
Jennifer L Shepard, James F Amatruda, Howard M Stern, et al.
Cancer Immunology Research
|
April 11, 2025
First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Metastatic Melanoma Patients
F Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie, et al.
JAMA Oncology
|
October 24, 2024
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial
Kartik Sehgal, Theodora Pappa, Kee-Young Shin, et al.
Nature Communications
|
December 31, 2024
Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma
Julia Paczkowska, Ming Tang, Kyle T Wright, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Positive Selection Screen for Natural Product β-Catenin Inactivators
Matthew W Boudreau, Vitor F Freire, Sophie C Corbett, et al.
Page
of 21